Christopher A Klebanoff

20PUBLICATIONS
103CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Mar 18, 2026
A post-translational regulatory map of chronic antigen-driven human T cell dysfunction.

Hiroyuki Kojima, Charlotte R Wayne, Luis F Somarribas Patterson

|Jan 24, 2026
CISH, a key intracellular checkpoint, in comparison and combination to existing and emerging cancer immune checkpoints.

Florencia Cano, Alberto Bravo-Blas, Mathilde Colombe

|Dec 16, 2025
The resting and ligand-bound states of the membrane-embedded human T-cell receptor-CD3 complex.

Ryan Q Notti, Fei Yi, Søren Heissel

|Oct 23, 2025
Engineering T cells with a membrane-tethered version of SLP-76 overcomes antigen-low resistance to CAR T cell therapy.

Maria Caterina Rotiroti, Aidan M Tousley, Hoyin Chu

|Jul 22, 2025
CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuit.

Fei Yi, Tal Cohen, Natalie Zimmerman

|Feb 19, 2025
Tumour-wide RNA splicing aberrations generate actionable public neoantigens.

Darwin W Kwok, Nicholas O Stevers, Iñaki Etxeberria

Pageof 4